They may also improve gut function, which is important for maintaining proper GLP-1 activity
What Phase 2 Data Tells Us to Expect The Phase 2 trial of retatrutide, published in The New England Journal of Medicine in 2023, provided an unusually clear preview of what TRIUMPH-1 might deliver
SVI is a measurement that evaluates communities ability to respond to natural disasters and public health crises
These treatments mimic the effects of GLP-1, helping patients manage their weight effectively
Our regulatory compliance attorneys combine deep regulatory healthcare experience with practical knowledge of how telehealth, pharmacy, and digital health businesses actually operate
Weight gain of 25 kg in the first month is typical, even in caloric deficit, due to glycogen retention and increased fluid volume